Insomnia in Primary Care
The Treatment of Insomnia in Primary Care: Evaluating and Improving Compliance to Clinical Practice Guidelines
2 other identifiers
interventional
485
1 country
1
Brief Summary
The goal of this clinical trial is to learn if training primary care providers on treatment of insomnia can improve insomnia symptoms in patients. Researchers will compare insomnia symptoms of patients receiving care from trained practices with patients receiving care from control practices (providing care-as-usual), to see if the training helps to provide improved insomnia care. Participants will be asked to complete four questionnaires and some participants will be invited for an insomnia consultation in primary care by their primary care providers (PCP).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 16, 2024
CompletedFirst Posted
Study publicly available on registry
August 28, 2024
CompletedStudy Start
First participant enrolled
September 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 13, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 13, 2026
CompletedMarch 30, 2026
December 1, 2025
1.5 years
August 16, 2024
March 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in patient reported insomnia symptoms using the Insomnia Severity Index (ISI)
Change is measured linearly using the Insomnia Severity Index. Scores range from 0 to 28 points in which higher scores represent a worse outcome. Secondly, the categorically defined treatment response is established 2 months after baseline questionnaire (remission = ISI score \< 11, ISI score reduction ≥ 8).
From baseline to measurements at 2, 6 and 12 months
Secondary Outcomes (6)
Patient reported non-pharmacological 'sleep consultation'
12 months after baseline questionnaire
Report by the PCP of a non-pharmacological 'sleep consultation'
12 months after baseline questionnaire
Change in patient reported depression symptoms
From baseline to measurements at 2, 6 and 12 months
Change in patient reported anxiety symptoms
From baseline to measurements at 2, 6 and 12 months
Change in patient reported general health status
From baseline to measurements at 2, 6 and 12 months
- +1 more secondary outcomes
Study Arms (3)
Training with pro-active identification
EXPERIMENTALFor detailed description of the intervention, see the separate section on interventions.
Training without pro-active identification
EXPERIMENTALFor detailed description of the intervention, see the separate section on interventions.
Control
NO INTERVENTIONCare as usual according to national applicable primary guide guidelines.
Interventions
A 4-hour training for PCPs consisting of an onsite training, an e-learning and a webinar on the treatment of insomnia.
Pro-active identification of patients with clinical insomnia symptoms. Patients receiving care from the participating practices will be asked to fill-out the Insomnia Severity Index (ISI).The ISI is used to identify patients with clinical insomnia symptoms in the general practice. Trained practices will receive feedback on the ISI for half of the patients with clinical symptoms according to the ISI.
Eligibility Criteria
You may qualify if:
- Patient registered with a participating primary care facility and willing to provide informed consent AND
- Survey confirmed presence of insomnia symptoms at least 3 times a week during at least the last 3 weeks AND
- Survey shown increased score on the Insomnia Severity Index (ISI ≥ 11) AND
- Survey shown interference with daily functioning on the Insomnia Severity Scale.
You may not qualify if:
- Patients meeting any of the following criteria in the survey will be excluded from participation in this study:
- Shift work for individuals awakening outside the hours 4:00 A.M. and 10:00 A.M. or going to bed outside the hours of 8:00 P.M. and 2:00 A.M. more than twice a week
- Other sleep-wake disorders including chronic obstructive sleep apnea, bruxism and narcolepsy, restless leg syndrome and parasomnia.
- Current pregnancy
- Presence of epilepsy, schizophrenia, bipolar disorder, post-traumatic stress disorder or dementia in medical history
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Leiden University Medical Center (LUMC)
Leiden, South Holland, 2333ZA, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dennis O. Mook-Kanamori
Leiden University Medical Center (LUMC)
- PRINCIPAL INVESTIGATOR
Rutger A. Middenburg
Leiden University Medical Center (LUMC)
- PRINCIPAL INVESTIGATOR
Mattijs E. Numans
Leiden University Medical Center (LUMC)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. dr. M.E. Numans
Study Record Dates
First Submitted
August 16, 2024
First Posted
August 28, 2024
Study Start
September 12, 2024
Primary Completion
March 13, 2026
Study Completion
March 13, 2026
Last Updated
March 30, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
Due to the nature of the study blinding is not possible. Therefore, the data contains privacy sensitive information and only restricted access may be granted for unidentifiable parts of the data. It has yet to be decided which data can be acquired through restricted access.